Cargando…

Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor

Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A midd...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruijing, Xue, Jingli, Liu, Wen, Jiang, Beibei, Shi, Fuyun, Wang, Zhenzheng, Li, Peifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070992/
https://www.ncbi.nlm.nih.gov/pubmed/37025961
http://dx.doi.org/10.3389/fmed.2023.1141353
_version_ 1785019103489032192
author Liu, Ruijing
Xue, Jingli
Liu, Wen
Jiang, Beibei
Shi, Fuyun
Wang, Zhenzheng
Li, Peifeng
author_facet Liu, Ruijing
Xue, Jingli
Liu, Wen
Jiang, Beibei
Shi, Fuyun
Wang, Zhenzheng
Li, Peifeng
author_sort Liu, Ruijing
collection PubMed
description Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A middle-aged female presented with a well-defined mass in the upper lobe of the right lung measuring 5.0 × 5.0 × 3.0 cm. The patient had a history of malignant phyllodes tumor in the breast. The patient underwent a right superior lobectomy. Histologically, the primary tumor was a typical malignant phyllodes tumor with pleomorphic liposarcomatous differentiation, while the lung metastasis showed osteosarcomatous differentiation without original biphasic features. The phyllodes tumor and heterologous components showed CD10 and p53 expression, and were negative for ER, PR, and CD34. Exome sequencing revealed TP53, TERT, EGFR, RARA, RB1, and GNAS mutations in all three components. Although the lung metastasis were morphologically different from the primary breast tumor, their common origin was demonstrated through immunohistochemical and molecular characterization. Cancer stem cells give rise to tumor heterogeneous cells, and heterologous components in malignant phyllodes tumors may indicate unfavorable prognosis and a greater risk of early recurrence and metastasis.
format Online
Article
Text
id pubmed-10070992
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100709922023-04-05 Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor Liu, Ruijing Xue, Jingli Liu, Wen Jiang, Beibei Shi, Fuyun Wang, Zhenzheng Li, Peifeng Front Med (Lausanne) Medicine Malignant phyllodes tumor is a rare breast tumor, with distant metastases and heterologous differentiation in a few cases. We report a case of malignant phyllodes tumor with liposarcomatous differentiation in the primary tumor and osteosarcomatous differentiation in the lung metastatic tumor. A middle-aged female presented with a well-defined mass in the upper lobe of the right lung measuring 5.0 × 5.0 × 3.0 cm. The patient had a history of malignant phyllodes tumor in the breast. The patient underwent a right superior lobectomy. Histologically, the primary tumor was a typical malignant phyllodes tumor with pleomorphic liposarcomatous differentiation, while the lung metastasis showed osteosarcomatous differentiation without original biphasic features. The phyllodes tumor and heterologous components showed CD10 and p53 expression, and were negative for ER, PR, and CD34. Exome sequencing revealed TP53, TERT, EGFR, RARA, RB1, and GNAS mutations in all three components. Although the lung metastasis were morphologically different from the primary breast tumor, their common origin was demonstrated through immunohistochemical and molecular characterization. Cancer stem cells give rise to tumor heterogeneous cells, and heterologous components in malignant phyllodes tumors may indicate unfavorable prognosis and a greater risk of early recurrence and metastasis. Frontiers Media S.A. 2023-03-21 /pmc/articles/PMC10070992/ /pubmed/37025961 http://dx.doi.org/10.3389/fmed.2023.1141353 Text en Copyright © 2023 Liu, Xue, Liu, Jiang, Shi, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Liu, Ruijing
Xue, Jingli
Liu, Wen
Jiang, Beibei
Shi, Fuyun
Wang, Zhenzheng
Li, Peifeng
Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title_full Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title_fullStr Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title_full_unstemmed Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title_short Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
title_sort case report: osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070992/
https://www.ncbi.nlm.nih.gov/pubmed/37025961
http://dx.doi.org/10.3389/fmed.2023.1141353
work_keys_str_mv AT liuruijing casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT xuejingli casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT liuwen casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT jiangbeibei casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT shifuyun casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT wangzhenzheng casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor
AT lipeifeng casereportosteosarcomatousdifferentiationinthelungmetastasisofamalignantphyllodestumor